JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265660

Human SHC4 (SHCD) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SHC4 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 4 and 4 bp deletion in exon 4.

View Alternative Names

MGC34023, RaLP, Rai-like protein, SH2 domain protein C4, SHC (Src homology 2 domain containing) family member 4, SHC adaptor protein 4, SHC family member 4, SHC-transforming protein 4, SHC-transforming protein D, SHC4_HUMAN, SHCD, Src homology 2 domain containing family member 4, Src homology 2 domain-containing-transforming protein C4, hShcD

2 Images
Sanger Sequencing - Human SHC4 (SHCD) knockout HeLa cell line (AB265660)
  • Sanger seq

Unknown

Sanger Sequencing - Human SHC4 (SHCD) knockout HeLa cell line (AB265660)

Allele-1 : 4 bp deletion in exon 4.

Sanger Sequencing - Human SHC4 (SHCD) knockout HeLa cell line (AB265660)
  • Sanger seq

Unknown

Sanger Sequencing - Human SHC4 (SHCD) knockout HeLa cell line (AB265660)

Allele-2 : 1 bp deletion in exon 4.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 4 and 4 bp deletion in exon 4

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265660-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265660 Human SHC4 (SHCD) knockout HeLa cell line", "number":"AB265660-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265660-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265660 Human SHC4 (SHCD) knockout HeLa cell line", "number":"AB265660-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SHC4
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SHC4 also known as SHCD is a member of the SHC (Src Homology 2 domain-containing) family and plays an important role in intracellular signaling. The protein has a molecular mass of approximately 72 kDa. SHC4 mainly localizes in the cytoplasm and can translocate to the membrane where it participates in signaling activities. Its expression occurs widely across different tissues but it shows a particularly strong expression in the nervous system indicating a potential role in neural processes.
Biological function summary

SHC4 serves as an adaptor protein that connects activated receptors to downstream signaling pathways. It can associate with various signaling complexes helping to mediate responses to extracellular stimuli. SHC4 transmits signals from receptors like receptor tyrosine kinases (RTKs) and plays a part in cellular functions such as proliferation and differentiation. These attributes highlight its involvement in complex networks that control cellular responses.

Pathways

SHC4 participates in signaling cascades like the MAPK/ERK and PI3K/AKT pathways. It interacts with proteins such as GRB2 which transmits signals from activated RTKs to the Ras protein ultimately influencing cell fate decisions. These pathways are critical for regulating cell cycle progression cellular growth and metabolism demonstrating SHC4's integral function in these processes.

SHC4 associates with conditions impacting the nervous system including neurodevelopmental disorders. Its altered signaling capability may relate to aberrant neural development affecting processes stabilized by SHC4. Moreover SHC4 has been studied in cancer where dysregulation of associated pathways like MAPK/ERK plays a significant role. Its interaction with proteins such as RAS which can act as oncogenes when mutated marks SHC4 as an important protein in oncology research.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com